Physician profile
Robert Pepper
NPI 1902364383
$370.81
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.62 · 2023: $201 · 2024: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $351.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $118.69 | 2023-2024 | Accrufer |
| Smith+Nephew, INC. | $44.63 | 2024 | Collagenase Santyl |
| Exact Sciences Corporation | $43.50 | 2023-2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $29.60 | 2023 | Mounjaro |
| Vital Connect, INC | $29.16 | 2024 | Vitalpatch Rtm |
| Dexcom, INC. | $22.09 | 2023 | Dexcom G6 Transmitter |
| Becton, Dickinson and Company | $20.72 | 2023 | Phasix Mesh |
| Amgen INC. | $19.62 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.60 | 2023 | Xifaxan |
| Convatec INC. | $13.51 | 2024 | |
| Kerecis Limited | $11.69 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Pepper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.